WSO December 2023 – Issue 3 - 1254

1254
International Journal of Stroke 18(10)
24. Soderholm M, Pedersen A, Lorentzen E, et al. Genomewide
association meta-analysis of functional outcome after
ischemic stroke. Neurology 2019; 92: e1271-e1283.
25. Burgess S, Bowden J, Fall T, Ingelsson E and Thompson
SG. Sensitivity analyses for robust causal inference from
Mendelian randomization analyses with multiple genetic variants.
Epidemiology 2017; 28: 30-42.
26. Bowden J, Davey Smith G and Burgess S. Mendelian randomization
with invalid instruments: effect estimation and bias
detection through Egger regression. Int J Epidemiol 2015; 44:
512-525.
27. Pichler I, Del Greco M F, Gögele M, et al. Serum iron levels
and the risk of Parkinson disease: a Mendelian randomization
study. PLoS Med 2013; 10: e1001462.
28. Davies NM, Holmes MV and Smith GD. Reading Mendelian
randomisation studies: a guide, glossary, and checklist for clinicians.
BMJ 2018; 362: k601.
29. Verbanck M, Chen CY, Neale B, et al. Detection of widespread
horizontal pleiotropy in causal relationships inferred
from Mendelian randomization between complex traits and
diseases. Nat Genet 2018; 50: 693-698.
30. Flossmann E, Schulz UG and Rothwell PM. Systematic
review of methods and results of studies of the genetic epidemiology
of ischemic stroke. Stroke 2004; 35: 212-227.
31. Yavorska OO and Burgess S. MendelianRandomization: an
R package for performing Mendelian randomization analyses
using summarized data. Int J Epidemiol 2017; 46, 1734-1739.
32. Carey RM, Moran AE and Whelton PK. Treatment of hypertension:
a review. JAMA 2022; 328: 1849-1861.
33. Barzegar M, Vital S, Stokes KY, et al. Human placenta mesenchymal
stem cell protection in ischemic stroke is angiotensin
converting enzyme-2 and masR receptor-dependent. Stem
Cells 2021; 39: 1335-1348.
34. Ma TT, Wong ICK, Whittlesea C, et al. Impact of multiple
cardiovascular medications on mortality after an incidence of
ischemic stroke or transient ischemic attack. BMC Med 2021;
19: 24.
35. Di Napoli M and Papa F. Angiotensin-converting enzyme
inhibitor use is associated with reduced plasma concentration
of C-reactive protein in patients with first-ever ischemic
stroke. Stroke 2003; 34: 2922-2929.
36. Dandona P, Dhindsa S, Ghanim H and Chaudhuri A.
Angiotensin II and inflammation: the effect of angiotensinconverting
enzyme inhibition and angiotensin II receptor
blockade. J Hum Hypertens 2007; 21: 20-27.
37. Chitravas N, Dewey HM, Nicol MB, et al. Is prestroke use
of angiotensin-converting enzyme inhibitors associated with
better outcome? Neurology 2007; 68: 1687-1693.
38. Hassan Y, Aziz NA, Al-Jabi SW, Looi I and Zyoud SH. Impact
of angiotensin-converting enzyme inhibitors administration
prior to acute ischemic stroke onset on in-hospital mortality.
J Cardiovasc Pharmacol Ther 2010; 15: 274-281.
39. Zonneveld TP, Richard E, Vergouwen MD, et al. Blood pressure-lowering
treatment for preventing recurrent stroke, major
vascular events, and dementia in patients with a history of
stroke or transient ischaemic attack. Cochrane Database Syst
Rev 2018; 7: CD007858.
40. Su YY, Li HM, Yan ZX, et al. Renin-angiotensin system
activation and imbalance of matrix metalloproteinase-9/tissue
inhibitor of matrix metalloproteinase-1 in cold-induced
stroke. Life Sci 2019; 231: 116563.
41. Shih CJ, Chen HT, Chao PW, et al. Angiotensin-converting
enzyme inhibitors, angiotensin II receptor blockers and the risk
of major adverse cardiac events in patients with diabetes and
prior stroke: a nationwide study. J Hypertens 2016; 34: 567-74.
42. Hsieh YC, Hung CY, Li CH, et al. Angiotensin-receptor
blocker, angiotensin-converting enzyme inhibitor, and risks of
atrial fibrillation: a nationwide cohort study. Medicine 2016;
95: e3721.
43. Zhao JV, Liu F, Schooling CM, Li J, Gu D and Lu X. Using
genetics to assess the association of commonly used antihypertensive
drugs with diabetes, glycaemic traits and lipids: a
trans-ancestry Mendelian randomisation study. Diabetologia
2022; 65: 695-704.
44. Maïer B, Gory B, Taylor G, et al. Mortality and disability
according to baseline blood pressure in acute ischemic stroke
patients treated by thrombectomy: a collaborative pooled
analysis. J Am Heart Assoc 2017; 6: e06484.
45. Paternoster L, Tilling K and Davey Smith G. Genetic epidemiology
and Mendelian randomization for informing disease
therapeutics: conceptual and methodological challenges.
PLoS Genet 2017; 13: e1006944.
International Journal of Stroke, 18(10)
WSO December 2023 – Issue 3

Table of Contents for the Digital Edition of WSO December 2023 – Issue 3
